Rohto Pharmaceutical Co.,Ltd. (4527.T) JPX
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
Rohto Pharmaceutical Co.,Ltd.
Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
7259
First IPO Date
January 04, 2001
Key Executives
| Name | Title | Pay | Year Born |
| Masae Yamanaka | Chief Transformation Officer & Director | 0 | 1963 |
| Yoko Fujimoto | MD, Chief Medical Officer & Director | 0 | 1965 |
| Hidetoshi Segi | Chief Operating Officer, President & Representative Director | 0 | 1962 |
| Yoichi Honma | Chief Scientific Officer & Director | 0 | 1968 |
| Saito Masaya | Executive Vice President, Chief Financial Officer & Director | 0 | 1963 |
| Yasunori Kawasaki | Chief Human Resources Officer & Director | 0 | 1960 |
| Hideto Kamimura | Senior Executive Officer and General Manager of Marketing Division | 0 | N/A |
| Shinichi Kunisaki | Executive Vice President, Chief Technology Officer & Director | 0 | 1955 |
| Noriko Suenobe | Chief Research Officer & Director | 0 | 1966 |
Description
Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global entity engaged in the development, manufacturing, and marketing of a diverse array of pharmaceutical goods, beauty products, and nutritional supplements. Their comprehensive product line includes various ophthalmic solutions such as eye drops, contact lens care products, and eye washes. For skincare, they offer facial treatments like cleansers, toners, and creams, in addition to specialized medicated preparations for the skin. The company's offerings also extend to internal medicines, encompassing digestive aids, herbal remedies, and dietary supplements. Furthermore, they supply over-the-counter medications and deliver beauty and health services via dedicated counters. The company rebranded from Yamada Pharmaceutical to Rohto Pharmaceutical Co.,Ltd. in September 1949.